Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVE: Soft tissue augmentation in dermatologic surgery has evolved significantly, driven by the growing demand and popularity of noninvasive cosmetic procedures. This article examines the unique product characteristics, as well as their respective histories, used to guide selection for safe targeted volumization and optimized patient outcomes. MATERIALS AND METHODS: The range of agents used for noninvasive soft tissue augmentation were reviewed in the peer-reviewed literature, with an emphasis on the on-label and off-label use of those approved by the United States FDA. RESULTS: Shifting approaches to soft tissue augmentation over time represent the evolution of safe and effective ways to address patient concerns. A review of the available peer-reviewed literature demonstrates that since its inception, articles from the journal Dermatologic Surgery have helped guide current treatment protocols and future product development. CONCLUSION: Successful soft tissue augmentation requires an appreciation of both the characteristics of the available agents on the market and a comprehensive knowledge of human anatomy. The authors celebrate the role of the journal Dermatologic Surgery as a leading forum for advancing the field of soft tissue augmentation. It is through the dedication and innovation of these authors that they can optimize safety and successful patient outcomes.
No takes yet. Share an insight, caveat, or question.
Minokadeh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: